CareFusion Corp. (NYSE:CFN) announced that it acquired Rowa, a Germany-based robotic medication storage company, for $150 million this week.
Rowa develops automated pharmaceutical storage and retrieval systems, which CareFusion will combine with its own Pyxis line of dispensing and security systems. Rowa’s products include refrigerated storage and a stock input and management system.
Rowa is headquartered in Kelberg, Germany, and has operations in Italy, the Netherlands, Denmark and Sweden. The company has more than 300 employees, and boasts more than 3,500 installations in 30 countries.
"Since forming Rowa in 1996, we have focused on building a brand that is innovative and reliable with superior customer service," said Markus Willems, co-founder and managing director of Rowa, in a release. "Today, Rowa is one of the leading pharmacy robotics companies in Europe, and we look forward to taking our growth to the next level with CareFusion."
The acquisition is expected to be neutral to adjusted earnings in the first year and increasingly accretive thereafter. The deal is expected to close by the end of the first quarter of FY12.
Here’s a roundup of companies announcing mergers, acquisitions and divestitures.
- Olympus Corp. snags Spirus Medical
Olympus Corp. subsidiary Gyrus ACMI Inc. absorbed Spirus Medical Inc., effective July 1. All remaining Spirus’ Endo-Ease Discovery and Endo-Ease Vista Retrograde endoscope insertion assistance products will be distributed through the newly minted Spirus Medical LLC until inventory is exhausted, and no additional inventory will be added. Orders are only accepted from existing customers at this point.
- ResMed adds BiancaMed to its sleep apnea portfolio
San Diego-based sleep apnea device maker ResMed (NYSE:RMD) announced that it acquired BiancaMed Ltd. for an undisclosed amount. BiancaMed’s flagship technology is a motion sensor that can detect respiration and movement without physical contact with the human body. ResMed picked up all outstanding shares of BiancaMed stock this week.
- Axis-Shield resists Alere’s advances
Alere Inc.’s (NYSE:ALR) unsolicited $369 million acquisition offer was dumped by Scotland-based Axis-Shield, a competing diabetes test product maker. Axis-Shield’s stock jumped as much as 50 percent on news of the rejection, Bloomberg reported.